全球基因毒性检测市场规模、份额、趋势和成长分析报告（2026-2034年）

基因毒性测试市场预计将从 2025 年的 25.6 亿美元成长到 2034 年的 71.5 亿美元，2026 年至 2034 年的复合年增长率为 12.11%。

全球基因毒性检测市场正稳步成长，这主要得益于製药和生物技术产业对药物安全、化学风险评估以及监管合规性的日益关注。基因毒性检测对于在产品核可前识别致突变性和致癌性风险至关重要。研发投入的增加和临床试验管线的扩展正在加速市场需求。此外，人们对环境毒素和食品安全标准的日益重视也进一步推动了全球市场的扩张。

美国食品药物管理局 (FDA) 和欧洲药品管理局 (EMA) 等监管机构的严格规定是成长要素，这些规定要求製造商进行全面的遗传毒性评估。体外测试方法和替代性非动物模型的日益普及提高了效率并减少了伦理方面的担忧。包括自动化筛检平台和高通量测试系统在内的技术进步提高了准确性并缩短了周转时间。此外，将测试服务外包给合约研究组织 (CRO) 的增加也促进了收入成长。

未来几年，由于人工智慧 (AI) 和预测毒理学模型的融合应用，市场预计将呈现强劲的成长势头。随着新兴经济体加大对製药业的投资，服务供应商将迎来新的机会。生物标记识别和基因组学技术的持续创新将进一步提升检测能力。随着监管力度的加强和个人化医疗的普及，对可靠的基因毒性检测解决方案的需求预计将持续显着增长。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章 全球基因毒性检测市场：依产品划分

• 市场分析、洞察与预测
• 试剂和耗材
• 检测试剂盒
• 服务

第五章 全球基因毒性检测市场：依类型划分

• 市场分析、洞察与预测
• In Vitro
• In Vivo

第六章：全球基因毒性检测市场：依检测方法划分

• 市场分析、洞察与预测
• 彗星试验
• 微核试验
• 染色体畸变检测
• 基因突变检测
• 其他的

第七章 全球基因毒性检测市场：依应用领域划分

• 市场分析、洞察与预测
• 製药和生物技术
• 食品工业
• 化妆品产业
• 其他的

第八章 全球基因毒性检测市场：依地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第九章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第十章：公司简介

• 主要公司的市占率分析
• 公司简介
  • Laboratory Corporation Of America Holdings
  • Eurofins Scientific
  • Thermo Fisher Scientific Inc
  • Charles River Laboratories
  • Jubilant Ingrevia Limited
  • Syngene International Limited
  • Gentronix
  • Inotiv
  • Creative Bioarray
  • MB Research Laboratories

The Genetic Toxicology Testing Market size is expected to reach USD 7.15 Billion in 2034 from USD 2.56 Billion (2025) growing at a CAGR of 12.11% during 2026-2034.

The Global Genetic Toxicology Testing Market is experiencing steady growth due to the increasing focus on drug safety, chemical risk assessment, and regulatory compliance across pharmaceutical and biotechnology industries. Genetic toxicology tests are essential for identifying mutagenic and carcinogenic risks before product approval. Rising R&D investments and the expansion of clinical pipelines are accelerating demand. Moreover, growing awareness about environmental toxins and food safety standards further supports market expansion globally.

Stringent regulations imposed by agencies such as the FDA and EMA are major growth drivers, compelling manufacturers to conduct comprehensive genotoxicity assessments. The growing adoption of in vitro testing methods and alternative non-animal models is improving efficiency and reducing ethical concerns. Technological advancements, including automated screening platforms and high-throughput testing systems, are enhancing accuracy and turnaround time. Additionally, increasing outsourcing of testing services to CROs is contributing to revenue growth.

In the coming years, the market is expected to witness strong momentum with the integration of artificial intelligence and predictive toxicology models. Emerging economies are investing in pharmaceutical manufacturing, creating new opportunities for service providers. Continuous innovation in biomarker identification and genomic technologies will further refine testing capabilities. As regulatory scrutiny intensifies and personalized medicine expands, the demand for reliable genetic toxicology testing solutions will continue to rise significantly.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

• Reagents & Consumables
• Assays Kit
• Services

By Type

• In Vitro
• In Vivo

By Assay

• Comet Assay
• Micronucleus Assay
• Chromosomal Aberration Test
• Genetic Mutation Test
• Others

By Application

• Pharmaceutical & Biotechnology
• Food Industry
• Cosmetics Industry
• Other

COMPANIES PROFILED

• Laboratory Corporation of America Holdings, Eurofins Scientific, Thermo Fisher Scientific Inc, Charles River Laboratories, Jubilant Ingrevia Limited, Syngene International Limited, Gentronix, Inotiv, Creative Bioarray, MB Research Laboratories
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL GENETIC TOXICOLOGY TESTING MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Reagents & Consumables Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Assays Kit Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Services Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL GENETIC TOXICOLOGY TESTING MARKET: BY TYPE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Type
• 5.2. In Vitro Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. In Vivo Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL GENETIC TOXICOLOGY TESTING MARKET: BY ASSAY 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Assay
• 6.2. Comet Assay Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Micronucleus Assay Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Chromosomal Aberration Test Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Genetic Mutation Test Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL GENETIC TOXICOLOGY TESTING MARKET: BY APPLICATION 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast Application
• 7.2. Pharmaceutical & Biotechnology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Food Industry Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Cosmetics Industry Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.5. Other Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL GENETIC TOXICOLOGY TESTING MARKET: BY REGION 2022-2034(USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Product
  • 8.2.2 By Type
  • 8.2.3 By Assay
  • 8.2.4 By Application
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Product
  • 8.3.2 By Type
  • 8.3.3 By Assay
  • 8.3.4 By Application
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Product
  • 8.4.2 By Type
  • 8.4.3 By Assay
  • 8.4.4 By Application
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Product
  • 8.5.2 By Type
  • 8.5.3 By Assay
  • 8.5.4 By Application
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 South East Asia
  • 8.5.10 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Product
  • 8.6.2 By Type
  • 8.6.3 By Assay
  • 8.6.4 By Application
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL GENETIC TOXICOLOGY TESTING INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Laboratory Corporation Of America Holdings
  • 10.2.2 Eurofins Scientific
  • 10.2.3 Thermo Fisher Scientific Inc
  • 10.2.4 Charles River Laboratories
  • 10.2.5 Jubilant Ingrevia Limited
  • 10.2.6 Syngene International Limited
  • 10.2.7 Gentronix
  • 10.2.8 Inotiv
  • 10.2.9 Creative Bioarray
  • 10.2.10 MB Research Laboratories